I'm a little twisted and enjoy listening to finance podcasts while running ... Came across a great one today about the process & thought-work from large institutional biotech investment teams, Ted Seides interviewing Andy Acker (Portfolio Manager - Global Lifesciences & Biotechnology @ Janus Henderson).
Isn't Paradigm specific, but one I found interesting to hear professionals articulate a lot of what's spoken about in a variety of posts here.
Empty Rooms: Investing in Biotech at Janus Henderson - Capital Allocators with Ted Seides
Should be able to listen via the link above, or by hunting through your podcast platform of choice for Capital Allocators - Ep. 274
research reports and media, page-3346
-
- There are more pages in this discussion • 1,083 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $2.253K | 11.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 277958 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 164157 | 5 |
View Market Depth
| Last trade - 10.06am 07/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |